Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.
NDWRH and Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of vaccines for the treatment and prevention of infectious diseases and cancer, see the first woman in the UK receive the first dose of a novel therapeutic HPV vaccine for the HPV001 clinical trial in Oxford.
A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.
In a record breaking year for the Postgrad Awards 2021, DPhil student Tolu Awoyemi wins PhD Student of the Year.\r\nThe award recognises the individual PhD student who has become an excellent and inquisitive researcher, who is an integral part of their research group, someone who encourages and supports more junior members of the team, and works alongside the research community more widely.
The Pfizer Maternal C-19 Vaccine Trial has launched at Oxford University Hospitals NHS Foundation Trust for women between 24-34 weeks pregnant. The Nuffield Department of Women\u2019s & Reproductive Health\u2019s team of doctors, research midwives and nurses are delivering this critical trial to evaluate the safety, tolerability, and immunogenicity of the Pfizer vaccine in pregnant women.
Further research into the relationship between brittle bones and women's heart disease risk could be beneficial suggest Drs Dexter Canoy and Kazem Rahimi at the Nuffield Dept of Women's & Reproductive Health.
The world's most comprehensive study of 345,000 people from 48 randomised clinical trials which revealed blood pressure-lowering medication is effective in adults, regardless of starting blood pressure level, is published in The Lancet.
A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised.
Listen now to the first episode \u2018Unheard of \u2013 The hidden voice of Endometriosis.\u2019 A bold new podcast series co-hosted by DPhil students Danielle Perro and Magda Mareckova, it seeks answers to the biggest questions posed by the Endometriosis community.
A world leading study involving over 260,000 participants has sought to resolve the long debated issue about whether using antihypertensive medication heightens the chance of developing cancer.
Professor Cecilia Lindgren (Prof of Genomic Endocrinology & Metabolism at the Nuffield Dept of Women's & Reproductive Health) has been appointed as the new Director of the University of Oxford\u2019s Big Data Institute.
A collaboration between Prof Ahmed's group at the Nuffield Dept of Women's & Reproductive Health and Dr Chunxiao Song\u2019s lab at the Ludwig Institute for Cancer Research, has established new sequencing methods for distinguishing DNA modifications. The paper: \"Subtraction-free and bisulfite-free specific sequencing of 5-methylcytosine and its oxidized derivatives at base resolution\" has been published in Nature Communications.
Nature\u2019s SAFE, Europe\u2019s first Living Biobank dedicated to preserving endangered animals has been launched with the mission to save animals from extinction, by harnessing regeneration and reproductive technologies developed via domestic animal breeding.
The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the \u2018Oxford Classic\u2019, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.
A new study led by the University of Oxford on over 90,000 participants shows that there is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease \u2013 \u2018every move counts towards better cardiovascular health.
![\"\"](\"https://www.wrh.ox.ac.uk/news/researchers-identify-genetic-cause-of-endometriosis-and-potential-drug-target/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n